Alana B. McNulty - 07 Sep 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
07 Sep 2021
Net transactions value
$0
Form type
3
Filing time
09 Sep 2021, 17:32:51 UTC
Previous filing
27 Aug 2021
Next filing
24 Jan 2022

No securities are beneficially owned.